Companies
Health Care
383 companies, ranked by market cap.
| Company | Sector | Market cap β | Price | Day | Revenue | Growth | Op. margin | P/E |
|---|---|---|---|---|---|---|---|---|
| Syndax Pharmaceuticals IncSNDX | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $172M | 627.8% | β158.4% | β |
| Harrow, Inc.HROW | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $272M | 36.4% | 11.2% | β |
| Janux Therapeutics, Inc.JANX | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $10.0M | β5.6% | β1,576.7% | β |
| Mannkind CorpMNKD | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $349M | 22.2% | 11.1% | β |
| Cryoport, Inc.CYRX | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $176M | 12.4% | β20.9% | β |
| Rigel Pharmaceuticals IncRIGL | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $294M | 64.1% | 42.6% | β |
| Kura Oncology, Inc.KURA | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $67.5M | 25.2% | β449.9% | β |
| Verastem, Inc.VSTM | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $30.9M | 209.1% | β550.3% | β |
| Ardelyx, Inc.ARDX | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $407M | 22.1% | β10.1% | β |
| Lexicon Pharmaceuticals, Inc.LXRX | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $49.8M | 60.2% | β98.2% | β |
| Design Therapeutics, Inc.DSGN | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $0.0M | β | β | β |
| Wave Life Sciences, Inc.WVE | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $42.7M | β60.5% | β504.1% | β |
| Avalo Therapeutics, Inc.AVTX | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $0.1M | β86.6% | β123,601.7% | β |
| Arbutus Biopharma CorpABUS | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $14.1M | 128.2% | β271.0% | β |
| Gyre Therapeutics, Inc.GYRE | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $117M | 10.2% | 9.9% | β |
| Zevra Therapeutics, Inc.ZVRA | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $106M | 350.9% | β59.1% | β |
| CorMedix Inc.CRMD | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $312M | 617.0% | 48.2% | β |
| Ironwood Pharmaceuticals IncIRWD | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $296M | β15.7% | 33.3% | β |
| Phathom Pharmaceuticals, Inc.PHAT | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $175M | 216.9% | β91.4% | β |
| Aclaris Therapeutics, Inc.ACRS | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $7.8M | β58.2% | β975.9% | β |
| Puma Biotechnology, Inc.PBYI | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $228M | β0.9% | 16.3% | β |
| Shattuck Labs, Inc.STTK | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $1.0M | β82.5% | β5,150.8% | β |
| CytomX Therapeutics, Inc.CTMX | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $76.2M | β44.8% | β29.3% | β |
| Neurogene Inc.NGNE | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $0.0M | β100.0% | β | β |
| Aquestive Therapeutics, Inc.AQST | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $44.5M | β22.6% | β159.5% | β |
| Crescent Biopharma, Inc.CBIO | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $10.8M | β | β1,407.5% | β |
| Ovid Therapeutics Inc.OVID | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $7.3M | 1,181.3% | β585.2% | β |
| Arvinas, Inc.ARVN | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $263M | β0.3% | β45.1% | β |
| Evolus, Inc.EOLS | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $297M | 11.6% | β11.0% | β |
| Monopar TherapeuticsMNPR | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $0.0M | β | β | β |
| Altimmune, Inc.ALT | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $0.0M | 105.0% | β230,461.0% | β |
| Assembly Biosciences, Inc.ASMB | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $72.3M | 153.5% | β16.8% | β |
| ARS Pharmaceuticals, Inc.SPRY | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $84.3M | β5.5% | β212.9% | β |
| Prothena Corp Public Ltd CoPRTA | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $9.7M | β92.8% | β2,216.4% | β |
| Opus Genetics, Inc.IRD | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $14.2M | 29.1% | β271.9% | β |
| Capricor Therapeutics, Inc.CAPR | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $0.0M | β100.0% | β | β |
| Enanta Pharmaceuticals IncENTA | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $65.3M | β3.4% | β130.7% | β |
| Emergent BioSolutions Inc.EBS | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $743M | β28.8% | 13.5% | β |
| Arcturus Therapeutics Holdings Inc.ARCT | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $82.0M | β46.1% | β93.0% | β |
| Prelude Therapeutics IncPRLD | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $12.1M | 73.4% | β861.3% | β |
| Fulcrum Therapeutics, Inc.FULC | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $0.0M | β100.0% | β | β |
| Standard Biotools Inc.LAB | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $85.3M | β6.2% | β129.2% | β |
| Abeona Therapeutics Inc.ABEO | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $5.8M | β | β1,536.9% | β |
| Q32 Bio Inc.QTTB | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $53.7M | β | 31.5% | β |
| Guardant Health, Inc.GH | Services-Medical Laboratories | β | β | οΏ½οΏ½ | $982M | 32.9% | β44.5% | β |
| Caris Life Sciences, Inc.CAI | Services-Medical Laboratories | β | β | οΏ½οΏ½ | $812M | 97.0% | 5.6% | β |
| GRAIL, Inc.GRAL | Services-Medical Laboratories | β | β | οΏ½οΏ½ | $147M | 17.2% | β382.0% | β |
| RadNet, Inc.RDNT | Services-Medical Laboratories | β | β | οΏ½οΏ½ | $2.0B | 11.5% | 3.0% | β |
| BillionToOne, Inc.BLLN | Services-Medical Laboratories | β | β | οΏ½οΏ½ | $305M | 100.0% | 5.3% | β |
| Veracyte, Inc.VCYT | Services-Medical Laboratories | β | β | οΏ½οΏ½ | $517M | 16.0% | 11.2% | β |